NextGen Healthcare Announces No Fee Version of NDSC’s CareSelect™ Imaging Through NextGen® Ambulatory EHR

Ensuring transparent education and intervention at the point of care

IRVINE, Calif.--()--NextGen Healthcare Information Systems, LLC, a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ:QSII) today proudly announced its agreement with National Decision Support Company (NDSC) to deliver a no fee version of its CareSelectTM Imaging solution, known as ACR Select™ Basic, to enable compliance with the requirements of the Protecting Access to Medicare Act of 2014 (PAMA), its associated AUC consultation requirements, and enable value-based imaging.

“We are delighted to partner with National Decision Support Company, the leading trusted decision support partner, for compliance with PAMA”

NextGen Healthcare selected ACR Select Basic as its exclusive solution to enable compliance for PAMA. “We are delighted to partner with National Decision Support Company, the leading trusted decision support partner, for compliance with PAMA,” said Justin Elliot, Senior Director of Product Management for NextGen Healthcare.

The no fee ACR Select Basic solution allows caregivers to consult Appropriate Use Criteria (AUC) in their native EMR workflow when ordering Medicare advanced imaging services. The result of this partnership is the robust capability to deliver a comprehensive set of structured indications and AUC from multiple qualified provider-led entities, including the American College of Radiology, into a single delivery platform. This enables full compliance with all aspects of PAMA for caregivers who order Medicare advanced imaging services. The partnership places end users at the forefront of compliance and quality through complete coverage and ensures that providers find the correct clinical test for every advanced imaging exam. Availability at the point of care ensures that the order generated results in a payable claim. It also provides a rich educational tool for caregivers and patients.

“Today, Healthcare organizations are investing in the appropriate reporting tools in time for the January 1, 2018 deadline specified by CMS,” said Elliot. Through collaborative agreements and partnerships, NextGen Healthcare is committed to providing actionable data at the point of care for informed clinical decisions.

About National Decision Support Company

The National Decision Support Company provides enterprise-wide Clinical Decision Support solutions that enable more efficient and appropriate care, improve population health, and save money. Our CareSelect Imaging technology platform converts published guidelines from credible, compliant content sources into actionable decision support criteria delivered directly into the EMR workflow.

About ACR Select™ Basic

ACR Select Basic provides direct integration of imaging decision support into Ambulatory EHRs to deliver a comprehensive range of Appropriate Use Criteria for diagnostic imaging. AUC is sourced from qualified Provider Led Entities (qPLE) including the American College of Radiology. Criteria is delivered directly into the EHR workflow to provide actionable, PAMA compliant decision support in real time.

About NextGen Healthcare

NextGen Healthcare, a wholly owned subsidiary of Quality Systems, Inc., helps ambulatory care organizations succeed in value-based care by empowering them to nurture measurably healthier patients and communities at a lower cost. It does this with deep clinical, financial, operational, and regulatory expertise, using consulting and educational services coupled with a robust technology portfolio of flexible, scalable, and cost-effective ambulatory solutions; including a certified EHR, practice management, interoperability, care management, patient engagement and population health management, analytics, e-transaction, and revenue cycle management solutions. For more information, visit www.nextgen.com. Follow NextGen Healthcare on Twitter, Facebook, or LinkedIn.

SAFE HARBOR PROVISIONS FOR FORWARD-LOOKING STATEMENTS

This news release may contain forward-looking statements within the meaning of the federal securities laws, including but not limited to, statements regarding future events, developments in the healthcare sector and regulatory framework, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue, net income, and earnings per share). Risks and uncertainties exist that may cause the results to differ materially from those set forth in these forward-looking statements. Factors that could cause the anticipated results to differ from those described in the forward-looking statements and additional risks and uncertainties are set forth in Part I, Item A of our most recent Annual Report on Form 10-K for the fiscal year ended March 31, 2016 and subsequently filed Quarterly Reports on Form 10-Q, including but not limited to: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; seasonal patterns of sales and customer buying behavior; impact of incentive payments under The American Recovery and Reinvestment Act on sales and the ability of the Company to meet continued certification requirements; the development by service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; disruptions caused by acquisitions of companies, products, or technologies; and general economic conditions. A significant portion of the Company's quarterly sales of software product licenses and computer hardware is concluded in the last month of a fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company's revenues and operating results are very difficult to forecast. A major portion of the Company's costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company's period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contacts

NextGen Healthcare
Shannan Bieler, 215-657-7010
sebieler@nextgen.com

Recent Stories

RSS feed for NextGen Healthcare Information Systems, LLC

NextGen Healthcare Information Systems, LLC